Device center's Thomas Tsakeris
This article was originally published in The Gray Sheet
Executive Summary
Director of the division of clinical laboratory devices in the device center's office of device evaluation submits resignation to ODE acting director Alan Andersen on Feb. 12. Tsakeris is leaving the agency on April 12 to join the Rockville, Maryland consulting firm of C. L. McIntosh. Former Center for Devices and Radiological Health staffers Walter Gundaker, Robert Sheridan and Edwin Miller also work at McIntosh. Tsakeris, who has served as DCLD director since 1990, is departing after 23 years with FDA. The agency has not yet named a successor.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.